Pluristem Therapeutics Signs Korean Licensing Deal: Includes $10 Million Share Swap

... medical centers and hospitals located in the US and Korea with in excess of two thousand beds under care, stem cell research centers, personal & preventive medicine and bio venture divisions. CHA Bio&Diostech has multiple stem cell R&D pipelines in ...

http://www.biospace.com/news_story.aspx?StoryID=301100&full=1